Free Trial

CAE (CAE) Financials

CAE logo
$27.08 +0.57 (+2.14%)
Closing price 05/6/2026 03:59 PM Eastern
Extended Trading
$27.76 +0.68 (+2.53%)
As of 05/6/2026 07:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for CAE

Annual Income Statements for CAE

This table shows CAE's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 3/31/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025
Net Income / (Loss) Attributable to Common Shareholders
189 268 248 219 -38 114 165 -219 289
Consolidated Net Income / (Loss)
193 275 256 225 -38 120 171 -219 289
Net Income / (Loss) Continuing Operations
193 275 256 225 -38 120 170 -235 289
Total Pre-Tax Income
219 299 300 277 -69 123 216 -288 357
Total Operating Income
274 359 361 378 39 228 345 -190 395
Total Gross Profit
609 681 707 764 610 766 801 853 904
Total Revenue
2,030 2,189 2,483 2,553 2,376 2,701 2,965 3,142 3,283
Operating Revenue
2,030 2,189 2,483 2,553 2,376 2,701 2,965 3,163 3,274
Other Revenue
- - - - - - - -21 9.25
Total Cost of Revenue
1,421 1,508 1,775 1,790 1,767 1,935 2,164 2,310 2,370
Operating Cost of Revenue
1,421 1,508 1,775 1,790 1,767 1,935 2,164 2,310 2,370
Total Operating Expenses
335 322 346 385 571 538 457 1,022 518
Selling, General & Admin Expense
274 295 312 308 318 392 371 395 393
Research & Development Expense
83 89 76 97 83 97 95 111 86
Impairment Charge
- - - - - - - 419 0.00
Restructuring Charge
27 - - 11 99 118 46 97 39
Total Other Income / (Expense), net
-54 -60 -61 -102 -108 -105 -128 -98 -38
Interest Expense
54 60 - - 108 105 128 151 150
Interest & Investment Income
- - - - - - - 53 112
Income Tax Expense
26 24 45 52 -32 2.88 46 -54 69
Net Income / (Loss) Discontinued Operations
-0.38 - - - - - - 16 0.00
Weighted Average Basic Shares Outstanding
- 267.74M 268.40M 265.45M 293.36M 317.02M 317.91M 318.31M 320.27M
Weighted Average Diluted Shares Outstanding
- 267.74M 268.40M 265.45M 293.36M 317.02M 317.91M 318.31M 320.27M
Weighted Average Basic & Diluted Shares Outstanding
- 267.74M 268.40M 265.45M 293.36M 317.02M 317.91M 318.31M 320.27M

Quarterly Income Statements for CAE

No quarterly income statements for CAE are available.


Annual Cash Flow Statements for CAE

This table details how cash moves in and out of CAE's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 3/31/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025
Net Change in Cash & Equivalents
14 83 -124 353 -16 -465 -95 -42 93
Net Cash From Operating Activities
349 313 399 -384 292 335 302 419 623
Net Cash From Continuing Operating Activities
349 313 399 384 292 302 304 389 669
Net Income / (Loss) Continuing Operations
193 275 256 225 -38 120 171 -219 289
Consolidated Net Income / (Loss)
193 275 256 225 -38 120 171 -219 289
Depreciation Expense
92 94 163 215 255 249 253 277 288
Non-Cash Adjustments To Reconcile Net Income
-39 -45 -25 15 135 -51 -30 245 -40
Changes in Operating Assets and Liabilities, net
35 -72 4.88 -71 -59 -17 -91 86 132
Net Cash From Investing Activities
195 -131 -1,036 -349 -274 -1,792 -296 -159 -509
Net Cash From Continuing Investing Activities
-175 -131 -1,036 -349 -274 -1,792 -274 -159 -509
Purchase of Property, Plant & Equipment
-196 -171 -254 -271 -130 -291 -292 -353 -309
Acquisitions
-12 -105 -622 -87 -164 -1,509 -4.73 0.00 -214
Sale of Property, Plant & Equipment
4.95 21 2.03 0.35 3.59 6.73 4.21 206 13
Sale and/or Maturity of Investments
12 120 -12 8.95 10 6.17 22 -5.02 6.75
Other Investing Activities, net
16 4.42 2.03 -1.06 6.45 -1.92 -3.48 -7.53 -6.47
Net Cash From Financing Activities
-136 -110 519 312 -17 1,006 -113 -292 -35
Net Cash From Continuing Financing Activities
-136 -110 519 312 -17 1,006 -113 -292 -35
Repayment of Debt
-593 -45 -71 279 -791 -178 -148 -618 -296
Repurchase of Common Equity
-31 -35 -71 -35 - - - 0.00 -15
Issuance of Debt
539 29 718 118 120 620 23 320 231
Issuance of Common Equity
9.53 12 14 19 654 558 12 5.76 47
Other Financing Activities, net
0.53 -2.25 4.28 10 -0.56 5.93 -0.15 0.00 -0.63

Quarterly Cash Flow Statements for CAE

No quarterly cash flow statements for CAE are available.


Annual Balance Sheets for CAE

This table presents CAE's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 3/31/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025
Total Assets
4,020 4,481 5,385 5,978 6,971 7,674 7,716 7,263 7,799
Total Current Assets
1,441 1,646 1,588 1,979 2,692 1,721 1,652 1,482 1,491
Cash & Equivalents
379 474 335 667 738 277 161 118 204
Short-Term Investments
18 10 15 18 26 22 8.95 5.32 16
Note & Lease Receivable
253 341 393 401 368 487 513 397 335
Accounts Receivable
412 350 373 399 413 446 455 461 426
Inventories, net
312 400 404 434 516 416 431 424 414
Prepaid Expenses
48 39 43 39 42 45 47 50 54
Current Deferred & Refundable Income Taxes
19 32 25 21 32 27 36 26 41
Plant, Property, & Equipment, net
1,188 1,398 1,615 1,518 1,569 1,706 1,765 1,858 2,079
Plant, Property & Equipment, gross
1,188 1,398 1,615 1,518 1,569 1,706 1,765 1,858 2,079
Total Noncurrent Assets
1,391 1,437 2,182 2,481 2,710 4,247 4,261 3,875 4,221
Long-Term Investments
296 197 244 334 347 372 399 438 390
Noncurrent Note & Lease Receivables
- - 0.00 279 246 299 316 403 548
Intangible Assets
709 818 1,524 1,449 1,638 3,041 2,995 2,416 2,692
Noncurrent Deferred & Refundable Income Taxes
32 47 53 60 84 94 92 172 133
Other Noncurrent Operating Assets
354 374 360 360 395 440 459 445 457
Total Liabilities & Shareholders' Equity
4,020 4,481 5,385 5,978 6,971 7,674 7,716 7,263 7,799
Total Liabilities
2,457 2,700 3,574 4,161 4,411 4,400 4,324 4,085 4,338
Total Current Liabilities
956 1,143 1,420 1,453 2,098 1,675 1,661 1,742 1,868
Short-Term Debt
51 54 211 230 183 215 190 249 307
Accounts Payable
522 517 664 658 754 781 767 765 828
Current Deferred & Payable Income Tax Liabilities
7.21 12 19 19 13 18 16 23 13
Other Current Liabilities
176 552 525 546 1,149 661 689 705 721
Total Noncurrent Liabilities
1,501 1,557 2,154 2,708 2,313 2,725 2,662 2,344 2,470
Long-Term Debt
903 937 1,551 2,189 1,701 2,247 2,244 2,042 2,136
Noncurrent Deferred & Payable Income Tax Liabilities
179 143 110 106 98 75 96 27 28
Noncurrent Employee Benefit Liabilities
118 156 160 150 177 88 68 73 93
Other Noncurrent Operating Liabilities
300 321 332 263 336 315 254 201 212
Total Equity & Noncontrolling Interests
1,562 1,781 1,811 1,817 2,560 3,274 3,393 3,178 3,461
Total Preferred & Common Equity
1,517 1,728 1,752 1,754 2,503 3,212 3,333 3,120 3,402
Preferred Stock
15 17 19 19 18 31 31 41 49
Total Common Equity
1,502 1,712 1,733 1,736 2,485 3,181 3,302 3,079 3,353
Common Stock
462 491 488 479 1,208 1,782 1,659 1,664 1,618
Retained Earnings
895 1,019 1,096 1,121 1,230 1,424 1,519 1,302 1,469
Accumulated Other Comprehensive Income / (Loss)
145 202 150 136 46 -25 124 114 266
Noncontrolling Interest
45 53 59 62 58 62 60 57 59

Quarterly Balance Sheets for CAE

No quarterly balance sheets for CAE are available.


Annual Metrics And Ratios for CAE

This table displays calculated financial ratios and metrics derived from CAE's official financial filings.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 3/31/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025
Growth Metrics
- - - - - - - - -
Revenue Growth
0.00% 7.82% 13.43% 2.83% -6.94% 13.67% 9.79% 5.97% 4.48%
EBITDA Growth
0.00% 18.64% -9.73% 28.07% -50.62% 62.52% 25.42% -85.51% 689.80%
EBIT Growth
0.00% 31.06% -16.28% 26.01% -89.81% 490.35% 51.32% -155.22% 307.74%
NOPAT Growth
0.00% 37.06% -6.89% 0.02% -91.22% 723.59% 21.78% -149.18% 339.75%
Net Income Growth
0.00% 42.76% -7.06% -12.07% -116.84% 417.49% 42.68% -227.63% 231.89%
EPS Growth
0.00% 37.63% -3.91% -5.69% -114.66% 364.71% 13.38% 0.00% 0.00%
Operating Cash Flow Growth
0.00% -10.29% 27.48% -196.38% 176.05% 14.69% -9.87% 38.66% 48.91%
Free Cash Flow Firm Growth
0.00% 0.00% -1,030.36% 112.01% 569.80% -541.75% 105.56% 97.94% -146.71%
Invested Capital Growth
0.00% 14.67% 42.48% 7.97% -13.69% 82.39% 3.08% -6.91% 8.76%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - - - - -
Gross Margin
29.99% 31.09% 28.49% 29.91% 25.65% 28.34% 27.02% 27.13% 27.54%
EBITDA Margin
21.32% 23.46% 18.67% 23.25% 12.34% 17.64% 20.15% 2.75% 20.82%
Operating Margin
13.48% 16.39% 14.55% 14.82% 1.62% 8.43% 11.62% -6.05% 12.04%
EBIT Margin
13.48% 16.39% 12.10% 14.82% 1.62% 8.43% 11.62% -6.05% 12.04%
Profit (Net Income) Margin
9.49% 12.56% 10.29% 8.80% -1.59% 4.45% 5.78% -6.96% 8.79%
Tax Burden Percent
87.79% 91.99% 85.09% 81.21% 54.47% 97.66% 79.31% 75.90% 80.79%
Interest Burden Percent
80.15% 83.32% 100.00% 73.11% -180.17% 54.05% 62.75% 151.55% 90.39%
Effective Tax Rate
12.04% 8.01% 14.91% 18.79% 0.00% 2.34% 21.41% 0.00% 19.21%
Return on Invested Capital (ROIC)
13.20% 16.86% 12.12% 9.92% 0.90% 5.67% 5.27% -2.64% 6.29%
ROIC Less NNEP Spread (ROIC-NNEP)
-5.22% -2.40% 5.12% 3.49% -7.12% -4.51% -0.23% -7.52% 4.55%
Return on Net Nonoperating Assets (RNNOA)
-0.87% -0.41% 2.11% 2.47% -2.63% -1.55% -0.12% -4.02% 2.40%
Return on Equity (ROE)
12.33% 16.45% 14.23% 12.39% -1.73% 4.12% 5.14% -6.66% 8.70%
Cash Return on Invested Capital (CROIC)
0.00% 3.19% -22.92% 2.25% 15.60% -52.68% 2.23% 4.51% -2.09%
Operating Return on Assets (OROA)
6.81% 8.44% 6.09% 6.66% 0.60% 3.11% 4.48% -2.54% 5.25%
Return on Assets (ROA)
4.79% 6.47% 5.18% 3.96% -0.58% 1.64% 2.23% -2.92% 3.83%
Return on Common Equity (ROCE)
11.86% 15.81% 13.65% 11.85% -1.67% 4.00% 5.00% -6.47% 8.43%
Return on Equity Simple (ROE_SIMPLE)
12.70% 15.91% 14.59% 12.81% -1.51% 3.74% 5.14% -7.01% 8.48%
Net Operating Profit after Tax (NOPAT)
241 330 307 307 27 222 271 -133 319
NOPAT Margin
11.86% 15.08% 12.38% 12.04% 1.14% 8.23% 9.13% -4.24% 9.72%
Net Nonoperating Expense Percent (NNEP)
18.42% 19.26% 7.00% 6.43% 8.02% 10.18% 5.49% 4.88% 1.75%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - 5.41%
Cost of Revenue to Revenue
70.01% 68.91% 71.51% 70.09% 74.35% 71.66% 72.98% 73.52% 72.18%
SG&A Expenses to Revenue
13.47% 13.49% 12.57% 12.08% 13.38% 14.51% 12.50% 12.57% 11.98%
R&D to Revenue
4.10% 4.07% 3.07% 3.80% 3.51% 3.58% 3.22% 3.52% 2.61%
Operating Expenses to Revenue
16.51% 14.70% 13.95% 15.08% 24.03% 19.91% 15.40% 32.53% 15.78%
Earnings before Interest and Taxes (EBIT)
274 359 300 378 39 228 345 -190 395
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
433 514 464 594 293 476 598 87 684
Valuation Ratios
- - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 3.38 1.95 3.04 2.40 2.17 2.13 2.33
Price to Tangible Book Value (P/TBV)
0.00 0.00 27.96 11.83 8.93 54.63 23.39 9.90 11.84
Price to Revenue (P/Rev)
0.00 0.00 2.36 1.33 3.18 2.83 2.42 2.09 2.38
Price to Earnings (P/E)
0.00 0.00 23.60 15.44 0.00 67.39 43.57 0.00 27.12
Dividend Yield
2.15% 1.94% 1.78% 3.41% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 4.24% 6.48% 0.00% 1.48% 2.30% 0.00% 3.69%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 2.38 1.51 2.83 1.88 1.75 1.73 1.85
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 2.86 1.91 3.31 3.53 3.08 2.67 2.97
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 15.31 8.20 26.79 20.01 15.28 96.93 14.29
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 23.64 12.86 203.65 41.87 26.50 0.00 24.71
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 23.10 15.84 290.93 42.88 33.72 0.00 30.59
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 17.81 0.00 26.89 28.45 30.24 20.04 15.67
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 69.75 16.80 0.00 79.45 36.88 0.00
Leverage & Solvency
- - - - - - - - -
Debt to Equity
0.61 0.56 0.97 1.33 0.74 0.75 0.72 0.72 0.71
Long-Term Debt to Equity
0.58 0.53 0.86 1.20 0.66 0.69 0.66 0.64 0.62
Financial Leverage
0.17 0.17 0.41 0.71 0.37 0.34 0.54 0.53 0.53
Leverage Ratio
2.57 2.54 2.75 3.13 2.96 2.51 2.31 2.28 2.27
Compound Leverage Factor
2.06 2.12 2.75 2.29 -5.33 1.36 1.45 3.46 2.05
Debt to Total Capital
37.92% 35.76% 49.32% 57.10% 42.40% 42.92% 41.77% 41.90% 41.38%
Short-Term Debt to Total Capital
2.01% 1.97% 5.91% 5.43% 4.13% 3.75% 3.25% 4.56% 5.20%
Long-Term Debt to Total Capital
35.91% 33.80% 43.41% 51.68% 38.28% 39.17% 38.52% 37.34% 36.18%
Preferred Equity to Total Capital
0.58% 0.60% 0.52% 0.45% 0.40% 0.54% 0.53% 0.75% 0.82%
Noncontrolling Interests to Total Capital
1.80% 1.91% 1.66% 1.47% 1.30% 1.07% 1.03% 1.05% 1.00%
Common Equity to Total Capital
59.71% 61.73% 48.50% 40.98% 55.90% 55.47% 56.66% 56.30% 56.80%
Debt to EBITDA
2.20 1.93 3.80 4.07 6.43 5.17 4.07 26.48 3.57
Net Debt to EBITDA
0.60 0.60 2.52 2.36 0.74 3.76 3.12 19.99 2.68
Long-Term Debt to EBITDA
2.09 1.82 3.35 3.69 5.80 4.72 3.76 23.60 3.12
Debt to NOPAT
3.96 3.00 5.74 7.87 69.81 11.07 8.99 -17.21 7.65
Net Debt to NOPAT
1.09 0.94 3.80 4.56 8.01 8.05 6.89 -12.99 5.74
Long-Term Debt to NOPAT
3.75 2.84 5.05 7.12 63.02 10.10 8.29 -15.34 6.69
Altman Z-Score
0.00 0.00 1.95 1.49 1.74 1.76 1.80 1.52 1.88
Noncontrolling Interest Sharing Ratio
3.83% 3.87% 4.10% 4.39% 3.59% 2.88% 2.76% 2.88% 3.10%
Liquidity Ratios
- - - - - - - - -
Current Ratio
1.51 1.44 1.12 1.36 1.28 1.03 0.99 0.85 0.80
Quick Ratio
1.11 1.03 0.79 1.02 0.74 0.74 0.69 0.56 0.53
Cash Flow Metrics
- - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 62 -581 70 468 -2,065 115 227 -106
Operating Cash Flow to CapEx
182.72% 207.67% 158.00% -142.14% 230.42% 118.00% 104.85% 285.74% 211.09%
Free Cash Flow to Firm to Interest Expense
0.00 1.04 0.00 0.00 4.33 -19.74 0.90 1.50 -0.71
Operating Cash Flow to Interest Expense
6.41 5.22 0.00 0.00 2.70 3.20 2.35 2.77 4.16
Operating Cash Flow Less CapEx to Interest Expense
2.90 2.71 0.00 0.00 1.53 0.49 0.11 1.80 2.19
Efficiency Ratios
- - - - - - - - -
Asset Turnover
0.51 0.52 0.50 0.45 0.37 0.37 0.39 0.42 0.44
Accounts Receivable Turnover
4.93 5.74 6.87 6.62 5.85 6.29 6.58 6.86 7.40
Inventory Turnover
4.55 4.23 4.42 4.27 3.72 4.15 5.11 5.40 5.66
Fixed Asset Turnover
1.71 1.69 1.65 1.63 1.54 1.65 1.71 1.73 1.67
Accounts Payable Turnover
2.72 2.90 3.01 2.71 2.50 2.52 2.80 3.02 2.98
Days Sales Outstanding (DSO)
74.01 63.54 53.15 55.16 62.38 58.07 55.48 53.23 49.30
Days Inventory Outstanding (DIO)
80.26 86.22 82.61 85.43 98.19 87.94 71.49 67.54 64.49
Days Payable Outstanding (DPO)
134.02 125.70 121.42 134.87 145.87 144.72 130.51 120.94 122.65
Cash Conversion Cycle (CCC)
20.24 24.06 14.35 5.71 14.70 1.30 -3.55 -0.18 -8.86
Capital & Investment Metrics
- - - - - - - - -
Invested Capital
1,824 2,091 2,980 3,217 2,777 5,064 5,220 4,859 5,285
Invested Capital Turnover
1.11 1.12 0.98 0.82 0.79 0.69 0.58 0.62 0.65
Increase / (Decrease) in Invested Capital
0.00 268 888 238 -441 2,288 156 -361 426
Enterprise Value (EV)
0.00 0.00 7,099 4,869 7,854 9,534 9,130 8,390 9,767
Market Capitalization
0.00 0.00 5,853 3,387 7,563 7,651 7,174 6,562 7,827
Book Value per Share
$0.00 $6.39 $6.47 $6.47 $9.36 $10.85 $10.41 $9.69 $10.53
Tangible Book Value per Share
$0.00 $3.34 $0.78 $1.07 $3.19 $0.48 $0.97 $2.09 $2.08
Total Capital
2,516 2,773 3,573 4,236 4,445 5,736 5,827 5,469 5,903
Total Debt
954 992 1,762 2,419 1,885 2,462 2,434 2,292 2,443
Total Long-Term Debt
903 937 1,551 2,189 1,701 2,247 2,244 2,042 2,136
Net Debt
262 310 1,169 1,400 216 1,790 1,865 1,730 1,832
Capital Expenditures (CapEx)
191 151 252 270 127 284 288 147 295
Debt-free, Cash-free Net Working Capital (DFCFNWC)
139 73 29 71 -544 -38 11 -134 -291
Debt-free Net Working Capital (DFNWC)
535 558 379 756 777 261 181 -10 -71
Net Working Capital (NWC)
485 503 168 526 594 46 -8.65 -260 -378
Net Nonoperating Expense (NNE)
48 55 52 83 65 102 99 86 31
Net Nonoperating Obligations (NNO)
262 310 1,169 1,400 216 1,790 1,827 1,682 1,824
Total Depreciation and Amortization (D&A)
159 155 163 215 255 249 253 277 288
Debt-free, Cash-free Net Working Capital to Revenue
6.84% 3.35% 1.18% 2.78% -22.90% -1.42% 0.38% -4.27% -8.87%
Debt-free Net Working Capital to Revenue
26.37% 25.48% 15.27% 29.60% 32.71% 9.66% 6.10% -0.33% -2.15%
Net Working Capital to Revenue
23.88% 22.99% 6.76% 20.60% 24.99% 1.70% -0.29% -8.27% -11.50%
Earnings Adjustments
- - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $1.29 $1.24 $1.17 ($0.17) $0.46 $0.70 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding
0.00 267.74M 268.40M 265.45M 293.36M 317.02M 317.91M 318.31M 320.27M
Adjusted Diluted Earnings per Share
$0.00 $1.29 $1.23 $1.16 ($0.17) $0.45 $0.70 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
0.00 267.74M 268.40M 265.45M 293.36M 317.02M 317.91M 318.31M 320.27M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 267.74M 268.40M 265.45M 293.36M 317.02M 317.91M 318.31M 320.27M
Normalized Net Operating Profit after Tax (NOPAT)
230 299 286 301 95 299 276 228 351
Normalized NOPAT Margin
11.33% 13.67% 11.52% 11.78% 3.98% 11.08% 9.32% 7.27% 10.69%
Pre Tax Income Margin
10.81% 13.66% 12.10% 10.84% -2.92% 4.56% 7.29% -9.18% 10.88%
Debt Service Ratios
- - - - - - - - -
EBIT to Interest Expense
5.04 5.99 0.00 0.00 0.36 2.18 2.68 -1.26 2.64
NOPAT to Interest Expense
4.43 5.51 0.00 0.00 0.25 2.13 2.11 -0.88 2.13
EBIT Less CapEx to Interest Expense
1.53 3.48 0.00 0.00 -0.82 -0.54 0.44 -2.22 0.67
NOPAT Less CapEx to Interest Expense
0.92 3.00 0.00 0.00 -0.92 -0.59 -0.13 -1.85 0.16
Payout Ratios
- - - - - - - - -
Dividend Payout Ratio
31.41% 25.35% 29.37% 34.78% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
47.66% 37.98% 57.13% 50.33% 0.00% 0.00% 0.00% 0.00% 5.13%

Quarterly Metrics And Ratios for CAE

No quarterly metrics and ratios for CAE are available.



Financials Breakdown Chart

Frequently Asked Questions About CAE's Financials

When does CAE's financial year end?

According to the most recent income statement we have on file, CAE's fiscal year ends in March. Their fiscal year 2025 ended on March 31, 2025.

How has CAE's net income changed over the last 8 years?

CAE's net income appears to be on a downward trend, with a most recent value of $288.62 million in 2025, rising from $192.62 million in 2017. The previous period was -$218.83 million in 2024. Check out CAE's forecast to explore projected trends and price targets.

What is CAE's operating income?
CAE's total operating income in 2025 was $395.23 million, based on the following breakdown:
  • Total Gross Profit: $904.17 million
  • Total Operating Expenses: $518.19 million
How has CAE's revenue changed over the last 8 years?

Over the last 8 years, CAE's total revenue changed from $2.03 billion in 2017 to $3.28 billion in 2025, a change of 61.7%.

How much debt does CAE have?

CAE's total liabilities were at $4.34 billion at the end of 2025, a 6.2% increase from 2024, and a 76.5% increase since 2017.

How much cash does CAE have?

In the past 8 years, CAE's cash and equivalents has ranged from $118.24 million in 2024 to $737.98 million in 2021, and is currently $204.26 million as of their latest financial filing in 2025.

How has CAE's book value per share changed over the last 8 years?

Over the last 8 years, CAE's book value per share changed from 0.00 in 2017 to 10.53 in 2025, a change of 1,053.5%.



Financial statements for NYSE:CAE last updated on 11/23/2025 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners